Bioactivity-guided fractionation of a methanol leaf extract from Gnetum africanum with potential anti-diabetic activity: (-)-Epicatechin as the active principle

Abstract

Dietary constituents of plants such as flavonoids are very important in ameliorating the challenges of metabolic disorders such as diabetes mellitus. The study evaluated the antidiabetic activities of fractions and a known flavonoid isolated from Gnetum africanum (Welw) of fasting blood sugar (FBS) in alloxan-induced diabetic albino rats. Antidiabetic activity-guided isolation by column chromatographic (CC) separation of methanol extract and purification of the most active CC fractions by semi-preparative high performance liquid chromatograpgy (HPLC) yielded a known flavonoid (GAF7.4) and four other uncharacterized fractions. The structure of GAF7.4 was elucidated based on the 1D and 2D NMR and HREIMS spectroscopic analyses. Antidiabetic activity was conducted by alloxan-induced FBS in diabetic rats model using glibenclamide as standard. The flavonoid (GAF7.4) was identified as (-)-epicatechin. The CC fraction 7 (50 mg/kg) elicited significant (p < 0.05) reduction in FBS of 42.3 % after 6 h. The isolated flavonoid (GAF7.4), 10 mg/kg dose caused a significantly higher reduction in FBS of 71.4 % in alloxan induced diabetic rats compared with 41.2 % reduction in glibenclamide (2 mg/kg) control. This represented the first report of epicatechin in G. africanum and our findings have contributed new knowledge to antidiabetic constitutents of the plants.

Keywords

• Gnetum africanum
• fasting blood sugar
• epicatechin
• antidiabetic.

References

1. [1] International Diabetes Federation. IDF Diabetes Atlas, 8th ed. Brussels, Belgium: International Diabetes Federation; 2017.
2. [2] International Diabetes Federation. IDF Diabetes Atlas, 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.
3. [3] Patterson CC, Dahlquist GG, Gyȕrȕ E, Green A, Soltesz G. EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009; 373(9680): 2027–2033.
4. [4] Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, ColagiuriS, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R, on behalf of the IDF diabetes atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Practice. 2019; 157: 107843. [CrossRef]
5. [5] Asgary S, Rafieian-Kopaei M, Shamsi F, Najafi S, Sahebkar A. Biochemical and histopathological study of the anti-hyperglycamic and anti-hyperlipidemic effects of cornelian cherry (Cornusmas L.) in alloxan-induced diabetic rats. J Complement Integr Med. 2014; 11(2): 63-69. [CrossRef]
6. [6] Khatik GL, ADatusalia AK, Ahsan W, Kaur P, Vyas M, Mittaland A, Nayak SK. A retrospective study on thiazole derivatives as the potential antidiabetic agents in drug discovery and development. Curr Drug Discov Technol. 2018;15(3): 163-177. [CrossRef]
7. [7] Uzor PF, Nnadi CO, Ahiabuike JE, Ani HN. Antidiabeticstudies and dereplication of the bioactive constituents of Anthocleistanobilis G. Don by UHPLC/ESI-QTOF-MS.Dhaka Univ J Pharm Sci.2018; 17(1):19-26.[CrossRef]
8. [8] Iwu MM, Handbook of African Medicinal Plants, second ed., Taylor and Francis, Boca Raton Florida 2010, pp. 224-226.

9. [9] Okafor JC, Conservation and use of traditional vegetables from woody forest species in Southeastern Nigeria, in: Proceedings of The IPGRI International Workshop on Genetic Resources of Traditional Vegetables in Africa: Conservadtion and Use -1995 Conference (Ed. L. Guarino), Nairobi, Kenya: ICRAF, 29th-31st August,1997, pp. 31-38.
10. [10] Udeh NE, Anaga AO, Asuzu IU. Fasting blood sugar and clinical biochemistry profiles of diabetic rats treated with methanol extract of Gnetumafricanum Welw.Indian JTrad Knowl. 2018; 17(3): 445-450.
11. [11] Udeh NE, Anaga AO, Asuzu IU. Protective effect of Gnetum africanum methanol leaf extract on pancreatic islets cells in rats. Comp ClinPathol. 2018; 27(3): 649-654. [CrossRef]
12. [12] Udeh NE, Anaga AO, Asuzu IU. Acute and sub-chronic oral toxicity studies on the methanol leaf extract of Gnetumafricanum Welw in wistar rats. Am J Res Med Sci. 2018; 3(1): 7-14. [CrossRef]
13. [13] Iweala EEJ, Uhegbu FD, Obidoa O. Biochemical and histological changes associated with long term consumption of Gnetum africanum Welw leaves in rats. Asian J Biochem. 2009; 4(4): 125-132. [CrossRef]
14. [14] OgbonnayaEC,, ChinedumEK. Health promoting compounds and in vitro antioxidant activity of raw and decoctions of Gnetum africanum welw, Asian Pac J Trop Dis. 2013; 3(6): 472-479. [CrossRef]
15. [15] Ilodibia CV, Ugwu RU, Nwokolo OL, Chukwuma MU, Akachukwu EE. Phytochemicalscreening, antifungal and antibacterial activity of aqueous and ethanolic leaf and stem extracts of Gnetum africanum Welw. Res J Med Plants. 2015; 9(6): 275-283. [CrossRef]
16. [16] Qi SH, Wu DG, Ma YB, Luo XD. A novel flavane from Carapaguianensis. Acta Bot Sin. 2003; 45(9): 1129 – 1133
17. [17] Spiegler V, Sendker J, Petereit F, Ziebau E, Hensel A. A bioassay guided fractionation of a leaf extract from Combretummucronatum with anthelmintic activity: Oligometricprocyanidins as the active principle. Molecules. 2015; 20(8):14810-14832.[CrossRef]
18. [18] Pizzolatti MG, Venson AF, Smania AJ, Smania EF, Braz-Filho R. Two epimeric flavalignans from Trichiliacontigua(Meliaceae) antiimicrobial activity. Zeitschr Naturforsch. 2002; 57(5-6): 483-488.[CrossRef]
19. [19] Fan P, Lou H, Yu W, Ren D, Ma B, Ji M. Novel flavanol derivatives from grape seeds, Tetrahedron Lett. 2004; 45(15): 3163–3166.
20. [20] Usman A, Thoss V,Itodo AU. Isolation of catechin from Trichiliaemetica whole seeds.Int JSci Global Sustain. 2016; 2(2): 81-85.
21. [21] Babatunde SB, Moyinoluwa OO, Oluwatosin A, Eigege W, Shreyans JK. Bioguidedisolation of an antioxidant compound from Combretumracemosum P Beave leaf.Int J Biol Chem. 2014; 8(5): 2339-2346. [CrossRef]
22. [22] Massini L, Rico D, Martin-Diana AB, Barry-Ryan C. Study of antioxidant properties of fractionated apple peel phenolics using a multiple assay approach. Int Food ResJ. 2016; 23(5): 1996-2005.
23. [23] Aminudin NI, Ahmad F, Taher M, Zulkifli M. Cytotoxic and antibacterial activities of constituents from Calophyllumferrugineum Ridley, Rec Nat Prod. 2016; 10(5): 649-653.
24. [24] Murni NS, Qamar UA, Alhassan MA, Suganya M, Vikneswari P. Antioxidant and antidiabetic effects of flavonoids: A structure-activity relationship based study. BioMed Res Int. 2017(2017): 1-14.[CrossRef]
25. [25] Soumyanath A, Traditional Medicines for Modern Times – Antidiabetic Plants, first ed., CRC Press, Boca Raton (FL) 2006.
26. [26] Mohan S, Nandhakumar L. Role of various flavonoids: Hypotheses on novel approach to treat diabetes. J Med Hypotheses and Ideas.2013; 8(1): 1-6. [CrossRef]
27. [27] Jiang ZJ, Xu SQ, Xing YU, Hu XM, Pan HY. Effects of flavonoids in Morusindica on blood lipids and glucose in hyperlipidemia–diabetic rats. Chin Herb Med. 2012; 4(4):314-318.[CrossRef]
28. [28] Jung MM, Park HC, Lee YH, Kang ES, Kim SK. Antidiabetic agents from medicinal plants. Curr Med Chem. 2006; 13(10): 1203-1218. [CrossRef]
29. [29] Subramanian S. Epicatechin as an anti- diabetic drug. Indian Drugs. 1981; 18: 259-261.
30. [30] Gutiérrez-Salmeán G, Meaney E, Lanaspa MA, Cicerchi C, Johnson RJ, Dugar S, Pam T, Ramírez-Sánchez I, Villarreal F, Schreiner G, Ceballos G.A randomized placebo-controlled, double-blind study on the effects of (-)-epicatechin on the triglyceride/HDLC ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects.Int J Cardiol. 2016; 223:500-506. [CrossRef]
31. [31] Ezuruike UF, Prieto JM. The use of plants in the traditional management of diabetes in Nigeria: Phamacological and toxicological considerations. J Ethnopharmacol. 2014; 155(2): 857- 924. [CrossRef]
32. [32] Trease GE, Evans WC. Pharmacognosy. 13th edition, BailliereTindall, London 1996, pp. 89-122, 313-544.